Califf Gains Wyden Support After Pledging Action On Accelerated Approval

By Beth Wang / February 10, 2022 at 5:00 AM
Senate Finance Committee Chair Ron Wyden (D-OR) will back FDA chief-nominee Robert Califf when his nomination comes to the Senate floor for a vote, the senator announced Thursday (Feb. 10) after Califf affirmed he would take strong action to make sure sponsors of drugs that make it to market under the accelerated approval pathway are held accountable for quickly gathering postmarket data. Califf said FDA would use “every authority at its disposal” to keep companies accountable under his helm, and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.